A new online petition drive is protesting the incredibly high prices that enormously overpaid pharmaceutical company CEOs charge for cancer drugs.
The basic idea behind innovative legislation now pending in our smallest state: The taxes we all pay should bankroll quality public services, not grand fortunes.
Should America’s taxpayers be subsidizing all those millions in compensation that CEOs are collecting? At least some members of Congress don’t think so.
The New York Times and the Washington Post have done some solid reporting on inequality. But this past week doesn’t rank among their finest moments.
The SEC finally moves, ever so slightly, against wagers that reward CEOs when their companies fail.
Can we trust Oxfam’s latest numbers on global inequality? Critics don’t think we should. But their pushback is getting pushback.
To save our democracy, a major new report on our grand divide never gets around to recognizing, we need to contemplate our plutocracy.
The typical American would be three-times richer if the United States distributed wealth as equally as France.
Is the world, as a whole, growing more or less unequal? Seems like this should be a fairly easy question to answer. But this simple question has no simple answer. Global inequality can be devilishly difficult to decipher.